“I love the NIH but post-pandemic, America’s biomedical sciences are at a crossroads." 


<div class="paywall-container">
<div class="textbox">
<h4 style="padding: 0 0 20px"> <a href="https://checkout.bostonherald.com/?&amp;g2i_or_o=Internet&amp;g2i_or_p=mg2pw20&amp;g2i_source=MD&amp;g2i_medium=sspw&amp;g2i_campaign=MG2PW20-sspw&amp;returnUrl=https3A2F2Fwww.bostonherald.com2F" aria-label="Subscribe to continue reading this article">Subscribe</a> to continue reading this article.<br> </h4>
<h4> Already subscribed? <a href="https://www.bostonherald.com/login?&amp;returnUrl=https%3A%2F%2Fwww.bostonherald.com%2F2025%2F03%2F05%2Ftrump-nih-director%2F" aria-label="Log in to your account">To login in, click here.</a> </h4>
</div>
</div>


Originally Published: <time datetime="2025-03-05 16:49:44">March 5, 2025 at 4:49 PM EST</time>

“I love the NIH but post-pandemic, America’s biomedical sciences are at a crossroads.”{ai:summary}<p>America's biomedical sciences face critical challenges in the post-pandemic landscape, highlighting the need for strategic direction and innovation. The National Institutes of Health (NIH) remains a key player in navigating this pivotal moment. </p><p>#health</p>

Trump nominee to lead National Institutes of Health questioned on funding cuts, vaccines

Subscribe to continue reading this article.

Already subscribed? To login in, click here.

Loading...